Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VIKAS LIFECARE LIMITED Capital/Financing Update 2021

May 17, 2021

60454_rns_2021-05-17_22be8325-7535-4f4f-89ff-eb364483438c.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [594 x 111] intentionally omitted <==

May 17, 2021

Listing Compliance Department Listing Compliance Department National Stock Exchange of India Limited. BSE Limited. Exchange Plaza, Bandra-Kurla Complex, Phirozee Jeejeebhoy Towers, Bandra (E), Mumbai 400051 Dalal Street, Fort, Fax: 022-26598235/36 Mumbai - 400 001 NSE Symbol: VIKASLIFE Scrip Code: 542655

NSE Symbol: VIKASLIFE

Sub: Intimation under Regulation 30 and 42 of the SEBI (LODR) Regulations, 2015, as amended (“SEBI Listing Regulations”) and outcome of the meeting of the Board of Directors of Vikas Lifecare Limited (the “Company”)

Dear Sir/ Madam,

This is further to our intimation on the outcome of the meeting of the Board of Directors of the Company (“Board”) dated February 6, 2021, where the issue of fully paid-up equity shares of the Company of face value of Re. 1/- each (“Equity Shares”) was approved by way of a rights issue for up to an aggregate amount of up to Rs. 50 Crore (Rupees Fifty Crore) (“Rights Issue”), in accordance with the Companies Act, 2013 and the rules made thereunder, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other applicable laws and our prior intimation dated May 11, 2021.

Pursuant to the above, we wish to inform that the Board of Directors at its meeting held today, May 17, 2021 have, inter alia, considered and approved the following terms of the Rights Issue:

Sl.No. Particulars Details
1. Type of securities proposed to beissued Fully paid-up Equity Shares of face value ofRe. 1/- each(“Rights EquityShares”)
2. Type of Issuance Rights Issue of fully paid-upEquityShares
3. Totalnumberofsecuritiesproposed to be issued Up to 26,53,98,198 fully paid-up Equity Sharesof face value of Re. 1/- each for an amountaggregatingupto 4909.87 Lakhs.
4. Issue Price Rs. 1.85/- per Rights Equity Share (includingpremium of Re. 0.85/-per Rights EquityShare
5. Record Date May 21, 2021 for the purpose of determining theequity shareholders entitled to receive therights entitlement in the Rights Issue (“EligibleEquityShareholders”)
6. Right Issue Period Rights Issue Opening Date: May 27, 2021Last date for On Market Renunciation of RightsEntitlement*: June 7, 2021Rights Issue Closing Date**: June 10, 2021*Eligible Equity Shareholders are requested toensure that renunciation through off-market
transfer is completed in such a manner that the

==> picture [593 x 33] intentionally omitted <==

==> picture [594 x 111] intentionally omitted <==

Rights Entitlements are credited to the demataccount of the Renouncees on or prior to theIssue Closing Date.**Our Board or a duly authorized Right Issuecommittee thereof will have the right to extendthe Issue period as it may determine from timeto time, provided that this Issue will not remainopen in excess of 30 days from the IssueOpening Date (inclusive of the Issue OpeningDate). Further, no withdrawal of Applicationshall be permitted by any Applicant after theIssue ClosingDate.
7. Rights Entitlement Ratio 2 Equity Shares for every 5 Equity Shares held bythe Eligible Equity Shareholders in the Companyas on the record date with the right torenounce.
8. Outstanding Equity Shares prior tothe Rights Issue 66,34,95,495 Equity shares of Re. 1/- each.
9. Outstanding Equity Shares postRightIssue(assumingfullsubscription) 92,88,93,693 Equity shares of Re. 1/- each.
10. Terms of payment Full amount of Rs. 1.85/- per Equity Sharepayable on application

The detailed terms of the Rights Issue including the procedure for applying in the Rights Issue and fractional entitlements will be specified in the Letter of Offer which will be filed by the Company with BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”) and with Securities and Exchange Board of India (“SEBI”) for record purpose only.

This intimation is issued in terms of Regulation 30 and 42 of the SEBI Listing Regulations.

The meeting was commenced at 05:30 P.M and concluded at 7:30 P.M

You are requested to take the information on record and oblige.

Thanking you,

Yours Faithfully, for Vikas Lifecare Limited (formerly Vikas Multicorp Limited)

==> picture [83 x 42] intentionally omitted <==

Rashika Gupta Company Secretary

==> picture [593 x 33] intentionally omitted <==